Evidence map›Paper›PMID 33038500›Full record

Trial reportContemporary clinical trials2020

A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.

Linnea A Polgreen, Barry L Carter, Philip M Polgreen, Peter M Snyder, Daniel K Sewell, Emine O Bayman, Shelby L Francis, Jacob E Simmering, Christopher Parker, Rachel Finkelstein

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Contemporary clinical trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Linnea A PolgreenDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, USA. Electronic address: linnea-polgreen@uiowa.edu.
Barry L CarterDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, USA; Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, USA.
Philip M PolgreenDepartment of Internal Medicine, College of Medicine, University of Iowa, USA; Department of Epidemiology, College of Public Health, University of Iowa, USA.
Peter M SnyderDepartment of Internal Medicine, College of Medicine, University of Iowa, USA.
Daniel K SewellDepartment of Biostatistics, College of Public Health, University of Iowa, USA.
Emine O BaymanDepartment of Biostatistics, College of Public Health, University of Iowa, USA; Department of Anesthesia, College of Medicine, University of Iowa, USA.
Shelby L FrancisDepartment of Internal Medicine, College of Medicine, University of Iowa, USA.
Jacob E SimmeringDepartment of Internal Medicine, College of Medicine, University of Iowa, USA.
Christopher ParkerDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, USA.
Rachel FinkelsteinDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, USA.

Funding

The University of Iowa Clinical and Translational Science AwardUL1TR002537 · NCATS · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R, WINOKUR, PATRICIA · 2018 to 2022
$20.0M
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional TextingR33HL144880 · NHLBI · UNIVERSITY OF IOWA · PI CARTER, BARRY L, POLGREEN, LINNEA ANN · 2020 to 2023
$2.6M
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional TextingR61HL144880 · NHLBI · UNIVERSITY OF IOWA · PI CARTER, BARRY L, POLGREEN, LINNEA ANN · 2019 to 2019
$693k
NCATS NIH HHS UL1 TR002537NHLBI NIH HHS R33 HL144880NHLBI NIH HHS R61 HL144880
6 · The paper itself

Abstract

backgroundNew approaches are needed to better monitor blood pressure (BP) between physician visits, especially for patients in rural areas or for those who lack transportation. We have developed a custom-built bi-directional texting platform for home BP measurements that can then be managed by clinical pharmacists located remotely. The purpose of this study is to evaluate whether the BP texting approach combined with a pharmacist-based intervention improves BP management and to determine if the approach is cost effective.

methodsThis study is a randomized, prospective trial in four primary care offices that serve patients in rural areas. Subjects will receive standardized research BP measurements at baseline, 6 and 12 months. The primary outcome will be differences between the intervention and control group in mean systolic BP at 12 months. Secondary outcomes will include systolic BP at 6 months; diastolic BP at 6 and 12 months, number of medication changes and costs.

conclusionsThis study plans to enroll subjects through 2022, follow-up will be completed in 2023 and results will be available in 2024. This study will provide information on whether a combined approach using texting of home BP values and a pharmacist-based telehealth services can improve BP control.

Indexed as

HypertensionText MessagingAntihypertensive AgentsBlood PressureHumansPharmacistsProspective StudiesAntihypertensive AgentsBlood pressure controlHypertension managementPharmacist management

Identifiers

PMID33038500
PMCPMC7686143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.